Logo image of CHSN

CHANSON INTERNATIONAL HOLD-A (CHSN) Stock Fundamental Analysis

NASDAQ:CHSN - Nasdaq - KYG2104U1076 - Common Stock - Currency: USD

0.3664  +0 (+0.38%)

After market: 0.3261 -0.04 (-11%)

Fundamental Rating

1

CHSN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 40 industry peers in the Consumer Staples Distribution & Retail industry. CHSN may be in some trouble as it scores bad on both profitability and health. CHSN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

CHSN had negative earnings in the past year.
In the past year CHSN has reported a negative cash flow from operations.
In multiple years CHSN reported negative net income over the last 5 years.
CHSN had a positive operating cash flow in 4 of the past 5 years.
CHSN Yearly Net Income VS EBIT VS OCF VS FCFCHSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 1M -1M -2M -3M

1.2 Ratios

The Return On Assets of CHSN (-0.59%) is worse than 66.67% of its industry peers.
The Return On Equity of CHSN (-1.89%) is worse than 66.67% of its industry peers.
Industry RankSector Rank
ROA -0.59%
ROE -1.89%
ROIC N/A
ROA(3y)-0.86%
ROA(5y)0.42%
ROE(3y)-30.34%
ROE(5y)-11.26%
ROIC(3y)N/A
ROIC(5y)N/A
CHSN Yearly ROA, ROE, ROICCHSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 50 -50 -100

1.3 Margins

CHSN's Profit Margin has declined in the last couple of years.
CHSN's Gross Margin of 43.43% is amongst the best of the industry. CHSN outperforms 89.74% of its industry peers.
In the last couple of years the Gross Margin of CHSN has remained more or less at the same level.
CHSN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-50.2%
GM growth 3Y-1.85%
GM growth 5Y-0.97%
CHSN Yearly Profit, Operating, Gross MarginsCHSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 20 40

More info and screens

1

2. Health

2.1 Basic Checks

CHSN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CHSN has more shares outstanding
The number of shares outstanding for CHSN has been increased compared to 5 years ago.
Compared to 1 year ago, CHSN has a worse debt to assets ratio.
CHSN Yearly Shares OutstandingCHSN Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
CHSN Yearly Total Debt VS Total AssetsCHSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

CHSN has an Altman-Z score of 0.40. This is a bad value and indicates that CHSN is not financially healthy and even has some risk of bankruptcy.
CHSN has a worse Altman-Z score (0.40) than 84.62% of its industry peers.
A Debt/Equity ratio of 0.26 indicates that CHSN is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.26, CHSN is doing good in the industry, outperforming 69.23% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 0.4
ROIC/WACCN/A
WACC6.75%
CHSN Yearly LT Debt VS Equity VS FCFCHSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 5M 10M

2.3 Liquidity

A Current Ratio of 0.71 indicates that CHSN may have some problems paying its short term obligations.
CHSN has a Current ratio of 0.71. This is amonst the worse of the industry: CHSN underperforms 87.18% of its industry peers.
A Quick Ratio of 0.66 indicates that CHSN may have some problems paying its short term obligations.
CHSN's Quick ratio of 0.66 is in line compared to the rest of the industry. CHSN outperforms 53.85% of its industry peers.
Industry RankSector Rank
Current Ratio 0.71
Quick Ratio 0.66
CHSN Yearly Current Assets VS Current LiabilitesCHSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 5M 10M

More info and screens

1

3. Growth

3.1 Past

CHSN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.23%, which is quite impressive.
The earnings per share for CHSN have been decreasing by -45.41% on average. This is quite bad
CHSN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -27.62%.
Measured over the past years, CHSN shows a small growth in Revenue. The Revenue has been growing by 7.60% on average per year.
EPS 1Y (TTM)84.23%
EPS 3YN/A
EPS 5Y-45.41%
EPS Q2Q%-92.96%
Revenue 1Y (TTM)-27.62%
Revenue growth 3Y18.72%
Revenue growth 5Y7.6%
Sales Q2Q%-14.4%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSN Yearly Revenue VS EstimatesCHSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 5M 10M 15M
CHSN Yearly EPS VS EstimatesCHSN Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CHSN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CHSN Price Earnings VS Forward Price EarningsCHSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CHSN Per share dataCHSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CHSN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHANSON INTERNATIONAL HOLD-A

NASDAQ:CHSN (2/21/2025, 8:08:48 PM)

After market: 0.3261 -0.04 (-11%)

0.3664

+0 (+0.38%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.05%
Inst Owner ChangeN/A
Ins Owners50.95%
Ins Owner ChangeN/A
Market Cap10.00M
AnalystsN/A
Price TargetN/A
Short Float %6.52%
Short Ratio0.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.63
P/FCF N/A
P/OCF N/A
P/B 0.83
P/tB 0.84
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS0.59
BVpS0.44
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.59%
ROE -1.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.43%
FCFM N/A
ROA(3y)-0.86%
ROA(5y)0.42%
ROE(3y)-30.34%
ROE(5y)-11.26%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-50.2%
GM growth 3Y-1.85%
GM growth 5Y-0.97%
F-Score3
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 92.16%
Cap/Sales 5.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.71
Quick Ratio 0.66
Altman-Z 0.4
F-Score3
WACC6.75%
ROIC/WACCN/A
Cap/Depr(3y)189.45%
Cap/Depr(5y)164.76%
Cap/Sales(3y)8.57%
Cap/Sales(5y)7.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.23%
EPS 3YN/A
EPS 5Y-45.41%
EPS Q2Q%-92.96%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-27.62%
Revenue growth 3Y18.72%
Revenue growth 5Y7.6%
Sales Q2Q%-14.4%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-167.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-530.92%
OCF growth 3YN/A
OCF growth 5YN/A